TV News LIES

Thursday, Aug 21st

Last update03:04:25 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Nothing to do with patient safety’: Ohio clinic to halt surgical abortions due to 2013 state law

Surgical abortions stop in OhioA suburban Cincinnati clinic will stop performing surgical abortions as a result of a 2013 state...

Patient info hacked, stolen from Community Health

Community helath hackedCommunity Health Systems Inc (CYH.N), one of the biggest U.S. hospital groups, said on Monday it...

Doctor with Ebola expected to be released from Atlanta hospital

Ebola doctor cured and released from hospitalThe American doctor being treated for Ebola at an Atlanta hospital has recovered and is expected...

Health Minister German outlaws fluoridation of all tap water

Fluoridation banned in IsraelContrary to the advice of public health and dentistry experts in her own ministry and academia,...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!